Home » Topics » Cardiovascular, BioWorld Science

Cardiovascular, BioWorld Science
RSS

Sankyo will seek FDA approval for temocapril HCl in 1997

June 28, 1996

Neurex seeks FDA approval for Corlopam

June 28, 1996

Endothelin antagonists in Kyowa Hakko's pipeline

June 28, 1996

Angiotensin II antagonists described by Sankyo

June 28, 1996

Roberts' ProAmatine approaches FDA approval

June 21, 1996

ST-899 and ST-776 claimed by Sigma-Tau

June 21, 1996

Vesnarinone treatment recommendations

June 21, 1996

L-arginine is effective in heart failure patients

June 21, 1996

TFPI as tissue injury inhibitor

June 21, 1996

Pierre Fabre reveals cardiac cytoprotective agents

June 21, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 16, 2026.
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
JPM 2026: Year kicks off with biopharma Q4 revenue and guidance
BioWorld
It was a battle of the companies with drugs for transthyretin-mediated amyloidosis on the first day of the J.P. Morgan 2026 Healthcare Conference with Alnylam...